CytomX Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

CytomX Therapeutics

08/11/2024 05:10

* CytomX Therapeutics Inc  CTMX.OQ  reported quarterly
adjusted
earnings of 7 cents​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of 4 cents.  The mean expectation of seven analysts
for the quarter was for a loss of 17 cents per share. Wall
Street expected results to range from -28 cents to -9 cents per
share.
    * Revenue rose 26.7% to $33.43 million from a year ago;
analysts
expected $17.51 million. 
    * CytomX Therapeutics Inc's reported EPS for the quarter was
7
cents​.
    * The company reported quarterly net income of $5.74
million.
    * CytomX Therapeutics Inc shares had fallen by 15.3% this
quarter and lost 35.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 6.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CytomX
Therapeutics Inc is $3.68 
This summary was machine generated from LSEG data November 8 at
05:10 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.17          0.07           Beat
 Jun. 30 2024      -0.14          -0.08          Beat
 Mar. 31 2024      -0.08          0.17           Beat
 Dec. 31 2023      -0.03          0.01           Beat